The latter has at least two subtypes with different biological properties. The subtypes can be identified by their genomic configuration. Using EBV-RNA (EBER) in situ hybridization and EBV polymerase chain reaction (PCR), we have looked for the presence of EBV in six LMGs and six non-Hodgkin's lymphomas (NHLs) located in the nasopharyngeal region, and determined the subtype of EBV. Six of six LMGs were positive by PCR and EBER in situ hybridization, whereas NHLs were either negative or, HE EPSTEIN-BARR VIRUS (EBV) has been impli-T cated in the pathogenesis of Burkitt's lymphoma, undifferentiated nasopharyngeal carcinoma or lymphomas in immunodeficient patients,' and, more recently, T-cell nonHodgkin's lymphomas (NHLs).' In large series of peripheral T-cell NHLs (PTCL) arising in the absence of overt immunodeficiency, the association with EBV was detected in 10% to 35% of patient^.^.^ Some subtypes ofT-lymphoproliferative lesions, such as angioimmunoblastic lymphadenopathy5 and angiocentric lymphoma^,^,^ are frequently accompanied by EBV. Angiocentric, polymorphous lymphoreticular infiltrates, primarily of midline facial structures and known as lethal midline granuloma (LMG), are T-cell NHLs and seem to be associated with EBV.' This combination has been observed mostly in Asian patients' and, more recently, in a French series of LMG." However, it was not clear for many years whether these lesions were true neoplasms possibly derived from T-lymphocytes. " Immunohistochemical analysis showed expression of antigens of peripheral T cells and, in some cases, coexpression of the natural killer (NK)-cell marker CD56 in LMG Further, cases with rearranged T-cell receptor genes, indicating a monoclonal T-cell proliferation, have been described. Midline granuloma is now considered to be a malignant lymphoma derived from peripheral T cells expressing gamma-delta chains of the T-cell receptor (TCR), having extensively lost the T-cell antigens, or from NK cells."
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The two subtypes of EBV, A and B, or 1 and 2, respectively, differ at the EBNA-2, -3, -4, and -6 gene loci.1h16 EBV-specific cytotoxic T lymphocytes can discriminate between cells infected with type l and type 2 v i r~s e s . "~'~ Type Supported by Grant no. 31-28744.90 2-infected lymphoblastoid cell lines in vitro show a poorer survival of individual cells, a lower growth rate, and a lower saturation density than lines established with type 1 virus." The subtype 2 was thought to occur in Africa and New Guinea, and the subtype I, worldwide, mainly in Europe, Japan, and North America." However, in Western populations, subtype 2 can regularly be isolated from oropharyngeal epithelial cells of healthy persons,20 whereas the peripheral blood B lymphocytes rarely carry subtype 2; malignant lymphomas (Hodgkin's and B-cell NHLs) of normal Western populations harbor almost exclusively subtype 1 .2' Type I has a greater capacity to transform B lymphocytes (in vitro) than type 2. In lymphoma patients with immunodeficiency, acquired or iatrogenic, subtype 2 is found in approximately half of case^.^*.'^ In the present study, we determined the subtypes of EBV in six LMG lymphomas from a Western population and confirmed the association of EBV and LMG by polymerase chain reaction (PCR) and RNA-in situ hybridization. We compared LMG to NHLs of the same anatomical localization with regard to EBV content.
Case Selection
Twelve lymphomas of the oropharanx, hypopharanx, or epipharynx and upper respiratory tract were selected from the files of the Institute of Pathology, Bern (Table 1) . Six T-cell lymphomas fulfilled the following morphological and clinical criteria of LMG: (1) nasal and midfacial involvement by pleomorphic lymphoma, displaying angiocentricity, angioinvasion, large areas of necrosis, and severe inflammatory reaction in many cases ( Fig 1A and B) ; (2) a clinically and histologically documented initial phase characterized by an inflammatory pattern (the follow-up time was between 1 and 9 years); (3) a T-cell phenotype, but sometimes with partial loss of some T-cell antigens (Figs 2 and 3) .
The other six NHLs, high-grade B-or T-cell lymphomas, were classified according to the updated Gel clas~ification~~ and the International Working Form~lation.'~
Immunophenotypic Analysis
Each of the 12 lymphomas was immunophenotyped using paraffin-embedded sections of formalin-fixed tissues and the following antisera: L26 (CD20), UCHLl (CD45RO), CD3 (Dako A452), OPD4 (CD45RO), and antibody Cs 1-4 directed against the latent membrane protein (LMP) of EBV. All antibodies were obtained from Dako (Copenhagen, Denmark). An avidin-biotin method was used with peroxidase and diaminobenzidine (DAB). Fresh-frozen material was not available. Therefore, more detailed immunophe- t EBER positivity is confined to few small lymphocytes.
MATERIALS AND METHODS
notypic studies and/or demonstration of clonal gene rearrangements, especially ofthe TCR genes could not be performed. Thus, a NK phenotype (CD56', CD2+) could not be established, since all available antibodies are not reactive in paraffin-embedded, formalin-fixed tissues, even after microwave treatment.
In Situ Hybridization
The methods have been described in detail in a previous Plasmid and probes. Genes for RNAs to be analyzed were cloned into SP6 vectors. The pJJJl vector, used for EBER1, was digested with Mst ll/PuVII, and the fragment containing 89% ofthe EBERl gene was treated with Klenow fragment and ligated into pSP65 digested with SmaI. After determining the orientation, the pSP65/EBER 1 plasmids (both orientations, sense and antisense) were digested with BamHI and transcribed to obtain RNAs of 175 nt (83% EBERI-specific). The RNA was labeled with digoxigenin-UTP using the RNA Labeling Kit (SP6/T7) from Boehringer Mannheim (Mannheim, Germany). Previously prepared probes and labeled probes were obtained from Professor H. Wolf, Regensburg, Germany.
Technique. In situ hybridization was performed on formalinfixed, paraffin-embedded tissues according to the method of Mac-
Mahon et
Hybrids were detected by use of the Boehringer Mannheim digoxigenin system. The sections were mounted without counterstaining.
Controls, interpretation. Sections of formalin-fixed, paraffinembedded EBV-positive R a j and B95.8 cells and of EBV-negative cells were used as positive and negative controls, respectively. Sections of EBV-positive lymphomas (as shown by previous Southern blot hybridization, PCR, and in situ hybridi~ation~'.~') were included in each batch ofexperiments. Hybridization with the digoxigenin system (Boehringer Mannheim) and nitroblue tetrazolium (NBT)-X-phosphate produces dark bluish-brown positive signals. Positive controls displayed a predominantly nuclear label, sometimes with visible exclusion of the nucleolus. All specimens that contained cells with a comparable hybridization signal were scored positive for EBER if the hybridization result with control probes (ie, EBER I -sense) was negative.
PCR
The paraffin block sections were processed and PCR was performed as described previou~ly.~~ Primers glycoprotein (gp)220 1 and gp220 2 were used together with an appropriate probe; the primers are specific for the gp220 region of the EBV genome. To define the subtypes of EBV, primers EBNA2 gen 1 and gen 2 were used as the outer primers in a seminested reaction with subtype-specific primers as the next step; each time, probes were applied to confirm the results. Primers, probes, and their sequences are listed in Table 2 . As control for the PCR, the @globulin gene was amplified in each case.29 Only cases with positive 0-globulin sequences were used for further EBV-PCR. Negative controls (water substituted for template DNA) were performed with each experiment. After Southern blot and hybridization with the appropriate end-labeled probes, the detection of positive bands was performed using the digoxigenin system. Samples of two cases of undifferentiated nasopharyngeal carcinomas and tonsillar tissue (two cases with infectious mononucleosis, three hyperplastic tonsils) were used as controls.
RESULTS
The results are summarized in Tables 1 and 3 . EBV-DNA was amplified by PCR with gp220 primers from six of 12 NHLs investigated. EBV-RNA (EBER) were detected by in situ hybridization in 9 of 12 lymphomas. All cases positive by both EBER in situ hybridization and by PCR (6 of 12) were T-cell lymphomas of the LMG type. EBER-positive elements in LMG, ie, large polymorphic tumor cells, were often found in the wall of vessels or in their vicinity (Fig 1A) .
Few EBER-positive cells, all considered to be nonneoplastic small lymphocytes, diffusely distributed over neoplastic tissue, were found in three NHLs studied for comparison (cases no. 7, 8, and 10). Hybridization with EBERI-sense probe always showed lack of annealing (Fig 1B) .
The T-cell phenotype of the LMG lymphomas established by use of monoclonal antibodies and paraffin-embedded tissues is outlined in Table 3 . The tumor cells in all LMGs reacted with the antibody UCHLl. In addition, four LMGs showed positive tumor cells after use of CD3 (Fig 2) , or of antibodies directed against OPD4 (Fig 3) , or of both compounds. In two cases (no. 2 and 3), the reactions (CD3, OPD4) were negative, possibly due to loss of antigens. Nevertheless, these cases fulfilled the morphological and clinical criteria of LMGs. In case no. 2, over the course of 6 years, a pleomorphic medium-to-large-cell lymphoma with extensive invasion of and damage to blood vessels destroyed extensively midline facial structures. In case no. 3, a LMG with a comparable morphology spread systematically. The patient died from generalized lymphoma, as shown at the autopsy. Clinical course is listed in Table 4 .
The subtype of EBV was determined in all LMG cases. Three cases had EBV type 2, and three cases had subtype 1 (Table 1 and Fig 4) . No double infections with both subtypes were found. All PCR results, particularly all subtypes, were then checked by hybridizing the amplified DNA with the corresponding digoxigenin labeled probes. The results were identical to those obtained by PCR alone: three of six EBV-positive LMGs had subtype 2 EBV.
Using a chi-square test for two independent samples and EBER-positivity alone as a criterion we found that the prevalence for EBV subtype 2 in LMG was significantly different from that in the other non-LMG lymphomas tested (P = .OS). The application of two criteria, ie, positivity by EBER and PCR, yielded a probability of .01.
The nasopharyngeal carcinomas and the tonsils with/ without infectious mononucleosis camed the subtype 1 of EBV. Carcinoma cells, as well as some cells in the tonsils with infectious mononucleosis, were LMP-positive. In LMGs, only one case showed a few scattered LMP-positive tumor cells.
DISCUSSION
In Western populations, T-cell NHLs are associated with EBV in a higher percentage than B-cell NHLs."~ This is unexpected because of the known B-cell tropism of EBV in vitro, partly explained by the fact that EBV-specific receptor CD21 is found on human B lymphocytes, but not on mature peripheral T cells.3o Some subtypes of T-cell NHLs, more prone to EBV-association than others, primarily present with a granulomatous3' or inflammatory aspect, such as T-cell NHL of the angioimmunoblastic lymphadenopathy with dysproteinemia (AILDktype,' and T-cell NHLs of the LMG type.' Both lesions were erroneously considered to be reactive diseases of the lymphatic Both the absence and the presence of TCR rearrangement have been reported in LMGs. In our series, clinical follow-up showed the malignant nature of these lesions. It is conceivable that the end stage of initially polyclonal LMGs might be clonal. However, there are no longitudinal data available to support this hypothesis. The T-cell nature of the cases in our series has been determined by immunohistochemistry on paraffin sections. The drawbacks of this technique are known. The density of available epitopes may be altered and thus differs from case to case, e& because of differences in fixation. Furthermore, immunohistochemical methods and criteria for evaluation may differ. These observations relate especially to differences seen with UCHLl and OPD4 in our series. Generally, OPD4 is thought to give a more reliable staining on paraffin sections than UCHL1. However, our cases had been collected from the files of the insti- The LMG type of T-cell lymphoma is regularly associated with EBV.""' It has been suggested that EBV replicates and resides in cells of the o r o p h a r y n~.~~"~ However, the issue of EBV-latency in oropharynx is still controversial. Therefore, it was tempting to suggest that oropharyngeal localization predisposes to the development of EBV-associated NHLs. However, in our series, EBV was confined to LMG; only a few EBV-positive cells, considered to be nonneoplastic small lymphocytes, were detectable in three of six NHLs from the same localization. Thus, in the nasopharyngeal region, the type of lymphoma, ie, LMG, disposes to an asso- Scant information is available on the distribution of viral subtypes in EBV-associated tumors. EBV type 2 occurs in 50% of EBV-positive N H L s " ,~~ of acquired immunodeficiency syndrome (AIDS) patients, both in lymphoma tissue and in lymphatic tissues without l y m p h~m a , *~.~~ whereas NHLs of normal populations carry subtype 1. To our knowledge, large series of lymphomas occurring in transplant recipients have not been tested for the EBV subtypes. Recently, we had the opportunity to study anaplastic large-cell lymphomas in two renal transplant patients. One lymphoma carried subtype 2, the other subtype 1 of EBV. Thus, subtype 2 may also occur in NHLs that develop during immunosuppressive therapy,28 perhaps as a result of a selection process. In apparently immunocompetent European individuals, Hodgkin's disease2' appeared to be mostly associated with subtype 1. The association of EBV type 2 with a T-cell NHL has been described in an immunocompetent Japanese person. 44 We are not aware of other published studies concerning the subtype distribution in larger series of NHLs in immunocompetent patients. In solid tumors, ie, nasopharyngeal carcinomas of patients from southern China, type 1 prevail^.^' In the present study, three of six of LMGs, considered to be a T-cell NHL variant, were associated with the type 2 of EBV. Our patients had no known immunodeficiency. The reason for this association is unknown. In some T-cell NHLs that present with a peculiar morphology, sometimes resembling a granulomatous reaction, such as in AILD NHL,46 a general, progressive immune dysregulation develops. Similarly, in LMG decreasing numbers of T-suppressor cells may indicate a disturbed immune statu^.^^.^' As LMG gradually develops, the dysregulation may result in particular histological features and a special clinical course in many, but not all patients. This hypothesis relates to the observed association of LMG to type 2 virus in the absence of an overt immunodeficiency. Further, cytotoxic T lymphocytes (CTL) can selectively recognize subtype 1 and 2 of EBV. ",I8 In the context of a possible dysfunction of T lymphocytes in LMG, virus-induced CD8+ T cells48 could select EBV subtypes in a different way, eg, type 1 in Hodgkin's disease, in apparently immunocompetent patients, and type 2 in NHLs associated with AIDS, drug-induced immunosuppression, or LMG.
